Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.
暂无分享,去创建一个
A. Aljada | R. Garg | P. Dandona | P. Mohanty | H. Ghanim | Wael Hamouda | E. Assian | Y. Kumbkarni
[1] A. Aljada,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Suppressive Effect of Dietary Restriction and Weight Loss in the Obese on the Generation of Reactive Oxygen Species by Leukocytes, Lipid Per , 2022 .
[2] A. Aljada,et al. Troglitazone Reduces Reactive Oxygen Species Generation by Leukocytes and Lipid Peroxidation and Improves Flow-Mediated Vasodilatation in Obese Subjects , 2000, Hypertension.
[3] E. Bey,et al. In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes. , 2000, Journal of lipid research.
[4] J. Corbett,et al. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. , 2000, Diabetes.
[5] D. Bharadwaj,et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. , 2000, The Journal of clinical investigation.
[6] A. Aljada,et al. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. , 2000, Circulation.
[7] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[8] A. Issekutz,et al. Enhancement of monocyte transendothelial migration by granulocyte‐macrophage colony‐stimulating factor: requirement for chemoattractant and CD11a / CD18 mechanisms , 1999, European journal of immunology.
[9] A. Aljada,et al. Increased IκB Expression and Diminished Nuclear NF-κB in Human Mononuclear Cells following Hydrocortisone Injection , 1999 .
[10] M. Lazar,et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. , 1999, The Journal of clinical investigation.
[11] J. Cidlowski,et al. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. , 1999, Endocrine reviews.
[12] Y. Takahashi,et al. Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus. , 1999, The American journal of cardiology.
[13] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[14] B. Staels,et al. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. , 1999, Current opinion in lipidology.
[15] A. Aljada,et al. Increase in plasma interleukin-10 following hydrocortisone injection. , 1999, The Journal of clinical endocrinology and metabolism.
[16] S. Devaraj,et al. α-Tocopherol Enrichment of Monocytes Decreases Agonist-Induced Adhesion to Human Endothelial Cells , 1998 .
[17] T. Wadden,et al. Tumor Necrosis Factor-α in Sera of Obese Patients: Fall with Weight Loss , 1998 .
[18] P. Dandona,et al. Effect of hydrocortisone on oxygen free radical generation by mononuclear cells. , 1998, Metabolism: clinical and experimental.
[19] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[20] S. Tanaka,et al. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. , 1998, The Journal of clinical endocrinology and metabolism.
[21] B. Seed,et al. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.
[22] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[23] P. Libby,et al. Short Communication Macrophages in Human Atheroma Contain PPARg Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor g (PPARg) Expression and Reduction of MMP-9 Activity through PPARg Activation in Mononuclear Phagocytes in Vitro , 1998 .
[24] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[25] J. Olefsky,et al. Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes , 1996, Diabetes.
[26] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[27] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[28] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[29] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[30] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[31] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[32] S. Chanock,et al. Isolation of a complex of respiratory burst oxidase components from resting neutrophil cytosol. , 1994, Biochemistry.
[33] T. Mosmann. Properties and functions of interleukin-10. , 1994, Advances in immunology.
[34] K. Wiktorowicz,et al. [Biological properties of interleukin 10]. , 1994, Postepy higieny i medycyny doswiadczalnej.
[35] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[36] M. Tosi,et al. A rapid, specific assay for superoxide release from phagocytes in small volumes of whole blood. , 1992, American journal of clinical pathology.
[37] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.
[38] M. Cybulsky,et al. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. , 1991, Journal of immunology.
[39] W. Nauseef,et al. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. , 1991, The Journal of clinical investigation.
[40] J. Hancock,et al. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. , 1987, The Biochemical journal.